Speece Thorson Capital Group Inc. raised its stake in Clorox Company (The) (NYSE:CLX) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 65,968 shares of the company’s stock after buying an additional 319 shares during the period. Speece Thorson Capital Group Inc.’s holdings in Clorox Company (The) were worth $8,790,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. Korea Investment CORP boosted its position in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the last quarter. Crossvault Capital Management LLC boosted its position in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the last quarter. Destination Wealth Management boosted its position in shares of Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares during the last quarter. Finally, Janney Capital Management LLC acquired a new position in shares of Clorox Company (The) during the first quarter valued at about $216,000. Institutional investors own 70.29% of the company’s stock.

Clorox Company (NYSE CLX) opened at 133.94 on Friday. The stock has a market capitalization of $17.29 billion, a price-to-earnings ratio of 25.11 and a beta of 0.40. The company has a 50 day moving average of $133.72 and a 200 day moving average of $133.47. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the company posted $1.30 earnings per share. The business’s revenue for the quarter was up 2.9% on a year-over-year basis. On average, equities analysts predict that Clorox Company will post $5.68 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Speece Thorson Capital Group Inc. Acquires 319 Shares of Clorox Company (The) (NYSE:CLX)” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/08/11/speece-thorson-capital-group-inc-acquires-319-shares-of-clorox-company-the-nyseclx.html.

Several research analysts have issued reports on CLX shares. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price on the stock in a report on Monday, April 24th. Jefferies Group LLC began coverage on shares of Clorox Company (The) in a report on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price on the stock. BMO Capital Markets restated a “buy” rating and issued a $136.00 price target on shares of Clorox Company (The) in a report on Thursday, May 4th. Finally, Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.